CellDetect® Bladder Cancer Kit Boosts the Detection of Low Grade Tumors in Urine Specimens

Please log in for more information

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Contant Information:

Micromedic Technologies Ltd., Kyriat Atidim, Building 3, Tel Aviv 6158101, Israel
Phone: +972-73-2753450
Fax: +972-73-2753451
Email: [email protected]

Visit website

CellDetect® is a Trademark of Zetiq Technologies, a fully-owned subsidiary of Micromedic. Micromedic Technologies Ltd. (TASE: MCTC) is engaged in the development and commercialization of unique solutions addressing substantial unmet needs in the field of cancer diagnostics, primarily early cancer detection.

Micromedic has initiated the process of engaging partners for the commercialization of the CellDetect® Bladder Cancer kit in Europe and countries adopting the CE regulatory standard. Selective European medical centers have already started using the product.